AI assistant
Sending…
Anterix Inc. — Director's Dealing 2020
Nov 20, 2020
33018_dirs_2020-11-19_f748d72c-417a-483b-992a-d50c2e1af243.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Anterix Inc. (ATEX)
CIK: 0001304492
Period of Report: 2020-11-10
Reporting Person: Guttman-McCabe Christopher (Chief Reg & Comm Officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 45610 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $25.75 | 2027-02-27 | Common Stock (11750) | Direct | |
| Stock Option (Right to Buy) | $32.50 | 2028-02-05 | Common Stock (8000) | Direct | |
| Stock Option (Right to Buy) | $42.14 | 2029-02-11 | Common Stock (6715) | Direct | |
| Stock Option (Right to Buy) | $34.40 | 2030-10-21 | Common Stock (62500) | Direct |
Footnotes
F1: Includes Restricted Stock Units in the amounts of (i) 5,000 shares vesting on December 15, 2020 and (ii) 30,572 shares that will vest in 4 equal annual installments beginning on November 15, 2021. Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's Common Stock.
F2: The option shares are fully vested.
F3: The option shares vest and become exercisable in 4 equal annual installments beginning on November 15, 2021.
More from Anterix Inc.
Regulatory Filings
2026
Apr 21
Regulatory Filings
2026
Apr 21
Regulatory Filings
2026
Apr 6
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Feb 11
Interim / Quarterly Report
2026
Feb 11
Regulatory Filings
2026
Feb 2
Major Shareholding Notification
2026
Jan 30
Regulatory Filings
2026
Jan 7
Director's Dealing
2025
Dec 19